Assessing HIVE Digital Technologies (TSXV:HIVE) Valuation After Recent Share Price Volatility

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.

HIVE Digital Technologies (TSXV:HIVE) has drawn investor attention after recent trading, with the share price at CA$3.03 and returns showing a 3.8% gain over the past day but a weaker picture over longer periods.

See our latest analysis for HIVE Digital Technologies.

The CA$3.03 share price comes after a mixed stretch, with a 1 day share price return of 3.77%, a 30 day share price return decline of 37.53%, and a 1 year total shareholder return loss of 24.44%, suggesting momentum has faded and recent moves may reflect shifting views on both growth prospects and risk.

If HIVE’s volatility has you looking around the market, it could be a moment to scan for other crypto exposed names using our 16 cryptocurrency and blockchain stocks as a starting list of ideas.

With HIVE showing strong annual revenue growth but sharp recent share price declines, the key question now is simple: are investors overlooking value here, or is the market already pricing in whatever future growth HIVE can deliver?

According to the most followed narrative, HIVE Digital Technologies’ fair value is set at CA$8.45, well above the recent CA$3.03 close, which frames the current debate around how much future growth is already reflected in the price.

HIVE Digital Technologies Ltd. (NASDAQ:HIVE, Equities researchers at HC Wainwright raised their FY2025 EPS estimates for shares of HIVE Digital Technologies in a research note issued on Thursday, November 14th. HC Wainwright analyst M. Colonnese now forecasts that the company will post earnings per share of ($0.33) for the year, up from their prior estimate of ($0.35). HC Wainwright has a “Buy” rating and a $8.00 price target on the stock. The consensus estimate for HIVE Digital Technologies’ current full-year earnings is ($0.27) per share. HC Wainwright also issued estimates for HIVE Digital Technologies’ Q4 2025 earnings at ($0.07) EPS and Q4 2026 earnings at $0.03 EPS.

Read the complete narrative.

Want to see what is driving that CA$8.45 fair value against a much lower share price? According to prajitdasani, the narrative leans heavily on a shift from current losses to future profitability, along with a richer earnings multiple than HIVE has today. Curious which revenue path and margin profile are baked into that view, and how they tie into that future P/E assumption? The full narrative lays out the numbers behind that gap.

Result: Fair Value of CA$8.45 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, there are clear pressure points here, including HIVE’s 88.4% annual net income decline, as well as the sharp multi year share price losses that could challenge bullish assumptions.

Find out about the key risks to this HIVE Digital Technologies narrative.

The user narrative points to a CA$8.45 fair value and an undervalued HIVE, but the simple earnings multiple tells a bumpier story. HIVE trades on a P/E of 16.1x, which is below the Canadian Software average of 35x yet well above its own fair ratio of 6.6x.

Put simply, the stock screens cheaper than peers but richer than the ratio our model suggests the market could settle around. That gap can cut both ways, so the real question for you is whether HIVE grows fast enough to justify staying above that fair ratio, or if the market reins the multiple back.

See what the numbers say about this price — find out in our valuation breakdown.

If you see HIVE’s story differently, or simply want to test the assumptions yourself, you can create your own view in a few minutes, Do it your way.

A great starting point for your HIVE Digital Technologies research is our analysis highlighting 2 key rewards and 5 important warning signs that could impact your investment decision.

If you are weighing up HIVE and do not scan the broader market, you risk missing other opportunities that might fit your style even better.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include HIVE.V.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com